| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3999337 | Urologic Oncology: Seminars and Original Investigations | 2016 | 9 Pages |
Abstract
Gene expression differences between high-grade and low-grade ccRCC may prove to be valuable biomarkers for advanced ccRCC. In addition, altered signaling between grades of ccRCC may provide important insight into the biology driving the progression of ccRCC and potential targets for therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Bryan J. Ph.D., Matthew M.D., Laura E. M.S., Timothy J. B.S., Barbara L. B.S., Samreen M.P.H., Amy Ph.D., Ping L. M.D., Ph.D., George D. Ph.D., Jason M.D.,